Danyu Du

机构：China Pharmaceutical University, Air Force Medical University · ORCID：0009-0004-4481-6359

发表论文 14 篇 · 总被引 1103 次 · h-index 9

代表论文

• Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma (2021 · Acta Pharmaceutica Sinica B · 被引 658)
• The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer (2020 · Investigational New Drugs · 被引 103)
• Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop (2017 · Oncotarget · 被引 94)
• The comprehensive landscape of miR-34a in cancer research (2021 · Cancer and Metastasis Reviews · 被引 87)
• Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner (2020 · Cell Death and Disease · 被引 35)
• MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells (2016 · Phytomedicine · 被引 32)